• 34 Citations
  • 3 h-Index
20182019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandro Armuzzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Inflammatory Bowel Diseases Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Safety Medicine & Life Sciences
Retrospective Studies Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Italy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

  • 34 Citations
  • 3 h-Index
  • 38 Article
  • 4 Review article
  • 1 Letter

Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign

Lenti, M. V., Armuzzi, A., Castiglione, F., Fantini, M. C., Fiorino, G., Orlando, A., Pugliese, D., Rizzello, F., Vecchi, M. & Di Sabatino, A., Jan 1 2019, (Accepted/In press) In : Digestive and Liver Disease.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
Venous Thromboembolism
Biological Products
Crohn Disease
Adrenal Cortex Hormones

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD), Favale, A., Onali, S., Caprioli, F., Pugliese, D., Armuzzi, A., Macaluso, F. S., Orlando, A., Viola, A., Fries, W., Rispo, A., Castiglione, F., Mocci, G., Chicco, F., Usai, P., Calabrese, E., Biancone, L., Monteleone, G. & Fantini, M. C., Oct 18 2019, In : Inflammatory Bowel Diseases. 25, 11, p. 1805-1812 8 p.

Research output: Contribution to journalArticle

Ulcerative Colitis
Survival
Therapeutics
vedolizumab
Adalimumab

Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease

Armuzzi, A., Riegler, G., Furfaro, F., Baldoni, M., Costa, F., Fortuna, M., Iaquinto, G., Paese, P., Papi, C., Bossa, F., Tontini, G. E., Di Fino, S., Gualberti, G., Merolla, R. & Rizzello, F., 2019, In : Digestive and Liver Disease. 51, 6, p. 804-811 8 p.

Research output: Contribution to journalArticle

Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease

Armuzzi, A., Riegler, G., Furfaro, F., Baldoni, M., Costa, F., Fortuna, M., Iaquinto, G., Paese, P., Papi, C., Bossa, F., Tontini, G. E., Di Fino, S., Gualberti, G., Merolla, R. & Rizzello, F., Jan 1 2019, (Accepted/In press) In : Digestive and Liver Disease.

Research output: Contribution to journalArticle

Crohn Disease
Ostomy
Medication Adherence
Therapeutics
Linear Models

Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study

Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD), Nov 1 2019, In : European journal of gastroenterology & hepatology. 31, 11, p. 1361-1369 9 p.

Research output: Contribution to journalArticle

Behavior Therapy
Inflammatory Bowel Diseases
Crohn Disease
Young Adult
Immunologic Factors